Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-23 Purchase | 2024-08-27 2:46 pm | abrdn Life Sciences Investors | HQL | Maher Bill Director | 650 | $15.37 | $9,991 | 1,715 (Indirect) | View |
| 2024-07-16 Purchase | 2024-07-18 2:56 pm | abrdn Life Sciences Investors | HQL | DiMartino Rose Director | 1,000 | $15.53 | $15,530 | 1,000 (Direct) | View |
| 2024-06-26 Purchase | 2024-06-27 11:22 am | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 100 | $14.07 | $1,407 | 3,429,991 (Indirect) | View |
| 2024-06-24 Purchase | 2024-06-25 5:36 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 13,812 | $14.08 | $194,473 | 3,429,891 (Indirect) | View |
| 2024-06-12 Purchase | 2024-06-14 1:59 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 10,867 | $13.83 | $150,326 | 3,416,079 (Indirect) | View |
| 2024-06-10 Purchase | 2024-06-11 5:03 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 11,743 | $13.72 | $161,098 | 3,405,212 (Indirect) | View |
| 2024-06-06 Purchase | 2024-06-10 08:45 am | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 13,361 | $13.78 | $184,081 | 3,393,469 (Indirect) | View |
| 2024-06-04 Purchase | 2024-06-05 5:09 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 59,440 | $13.61 | $809,222 | 3,380,108 (Indirect) | View |
| 2024-05-31 Purchase | 2024-06-03 5:11 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 21,369 | $13.29 | $283,994 | 3,320,668 (Indirect) | View |
| 2024-05-28 Purchase | 2024-05-31 3:08 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 47,416 | $13.14 | $623,176 | 3,299,299 (Indirect) | View |
| 2024-05-23 Purchase | 2024-05-23 7:41 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 1,303 | $13.5 | $17,591 | 3,251,883 (Indirect) | View |
| 2024-05-15 Purchase | 2024-05-17 12:34 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 34,755 | $14.19 | $493,173 | 3,250,580 (Indirect) | View |
| 2024-05-10 Purchase | 2024-05-14 1:50 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 57,862 | $13.86 | $801,967 | 3,215,825 (Indirect) | View |
| 2024-05-08 Purchase | 2024-05-10 10:31 am | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 28,359 | $13.76 | $390,256 | 3,157,963 (Indirect) | View |
| 2024-05-06 Purchase | 2024-05-07 5:07 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 60,874 | $13.74 | $836,126 | 3,129,604 (Indirect) | View |
| 2024-05-01 Purchase | 2024-05-02 4:50 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 26,526 | $13.46 | $356,929 | 3,068,730 (Indirect) | View |
| 2024-04-30 Purchase | 2024-05-01 10:23 am | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 16,573 | $13.13 | $217,603 | 3,042,204 (Indirect) | View |
| 2024-04-26 Purchase | 2024-04-29 4:54 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 120,304 | $13 | $1,563,952 | 3,025,602 (Indirect) | View |
| 2024-04-24 Purchase | 2024-04-26 11:40 am | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 118,103 | $13.01 | $1,536,827 | 2,905,298 (Indirect) | View |
| 2024-04-22 Purchase | 2024-04-23 8:00 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 50,225 | $13.14 | $659,913 | 2,787,195 (Indirect) | View |
| 2024-04-18 Purchase | 2024-04-22 3:08 pm | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 124,197 | $12.81 | $1,591,420 | 2,736,970 (Indirect) | View |
| 2024-04-09 Purchase | 2024-04-12 09:20 am | abrdn Life Sciences Investors | HQL | Goetz Kathleen Director | 400 | $13.32 | $5,327 | 1,085 (Direct) | View |
| 2024-01-02 Purchase | 2024-01-04 2:23 pm | abrdn Life Sciences Investors | HQL | Reit Todd Director | 1,000 | $13.8 | $13,798 | 1,000 (Direct) | View |
| 2023-12-28 Purchase | 2024-01-02 4:34 pm | abrdn Life Sciences Investors | HQL | Maher Bill Director | 1,000 | $13.57 | $13,570 | 1,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-06-18 3:18 pm | N/A N/A | abrdn Life Sciences Investors | HQL | Nichols Rebecca Suzanne Director of Adviser Director | 0 | $0 | 0 (Direct) | View |
Ownership | 2024-04-19 08:05 am | N/A N/A | abrdn Life Sciences Investors | HQL | Saba Capital Management L.P. Weinstein Boaz 10% Owner | 0 | $0 | 2,694,511 (Indirect) | View |